These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10695406

  • 1. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
    Miyamae T, Nakasima S, Imagawa T, Ito S, Katakura S, Tomono N, Mori M, Ibe M, Mitsuda T, Aihara Y, Yokota S.
    Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
    [Abstract] [Full Text] [Related]

  • 2. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 3. [Effects of therapies on childhood systemic lupus erythematosus].
    Kurosawa R, Umezawa R, Kobayashi Y, Nakajima S, Miyamae T, Ito S, Imagawa T, Katakura S, Mori M, Aihara Y, Yokota S.
    Ryumachi; 2003 Oct; 43(4):632-7. PubMed ID: 14598654
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.
    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.
    Ann Intern Med; 2001 Aug 21; 135(4):248-57. PubMed ID: 11511139
    [Abstract] [Full Text] [Related]

  • 5. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
    Cortés-Hernández J, Ordi-Ros J, Labrador M, Segarra A, Tovar JL, Balada E, Vilardell-Tarres M.
    Lupus; 2003 Aug 21; 12(4):287-96. PubMed ID: 12729052
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy.
    Kawasaki Y, Hosoya M, Suzuki J, Onishi N, Takahashi A, Isome M, Nozawa R, Suzuki H.
    Am J Nephrol; 2004 Aug 21; 24(6):576-81. PubMed ID: 15550753
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
    Tanaka Y, Yoshikawa N, Hattori S, Sasaki S, Ando T, Ikeda M, Honda M, Japanese Study Group for Renal Disease in Children.
    Pediatr Nephrol; 2010 May 21; 25(5):877-82. PubMed ID: 19902267
    [Abstract] [Full Text] [Related]

  • 8. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Kidney Int; 2006 Aug 21; 70(4):732-42. PubMed ID: 16820790
    [Abstract] [Full Text] [Related]

  • 9. Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.
    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct 21; 20(10):1500-3. PubMed ID: 16021476
    [Abstract] [Full Text] [Related]

  • 10. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Oct 21; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul 21; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of single dose of oral mizoribine pulse therapy two times per week for frequently relapsing nephrotic syndrome.
    Kawasaki Y, Takano K, Isome M, Suzuki J, Suyama K, Kanno H, Fujiki T, Suzuki H, Hosoya M.
    J Nephrol; 2007 Jul 21; 20(1):52-6. PubMed ID: 17347973
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
    Mima A.
    Rheumatol Int; 2017 Aug 21; 37(8):1387-1393. PubMed ID: 28255645
    [Abstract] [Full Text] [Related]

  • 14. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
    Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
    Clin Nephrol; 2012 Jul 21; 78(1):40-6. PubMed ID: 22732336
    [Abstract] [Full Text] [Related]

  • 15. Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts.
    Ruiz-Irastorza G, Ugarte A, Saint-Pastou Terrier C, Lazaro E, Iza A, Couzi L, Saenz R, Richez C, Porta S, Blanco P.
    Autoimmun Rev; 2017 Aug 21; 16(8):826-832. PubMed ID: 28564619
    [Abstract] [Full Text] [Related]

  • 16. [Effects of combined administration of prednisolone and mizoribine in the course of remission for SLE children with nephritis].
    Aihara Y, Ibe M, Mitsuda T, Mori M, Shimizu C, Takahashi Y, Kuriyama T, Yokota S.
    Ryumachi; 1994 Feb 21; 34(1):64-70. PubMed ID: 8146731
    [Abstract] [Full Text] [Related]

  • 17. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
    Gourley MF, Austin HA, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD.
    Ann Intern Med; 1996 Oct 01; 125(7):549-57. PubMed ID: 8815753
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 01; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 19. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
    Yee CS, Gordon C, Dostal C, Petera P, Dadoniene J, Griffiths B, Rozman B, Isenberg DA, Sturfelt G, Nived O, Turney JH, Venalis A, Adu D, Smolen JS, Emery P.
    Ann Rheum Dis; 2004 May 01; 63(5):525-9. PubMed ID: 15082482
    [Abstract] [Full Text] [Related]

  • 20. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T, Arai M, Ikeda M, Morita M, Watanabe Y, Hirama A, Shimizu A, Tsuruoka S.
    Int Urol Nephrol; 2015 Nov 01; 47(11):1823-30. PubMed ID: 26433884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.